NEW YORK (GenomeWeb) – Sophia Genetics announced today that its Hereditary Cancer Solution has received CE-IVD certification.

The genetic screen uses Integrated DNA Technologies' xGen Lockdown Probes to look at 27 genes relevant to breast, ovarian, and gastrointestinal hereditary cancers and includes specialized analytics developed by Sophia. The CE Mark applies to the combination of target capture technology and analytics, the firm said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.